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Abstract
Background and purpose: Huntington disease (HD) is an
au tosomal dominant hereditary neurodegenerative disease with
multiplication of CAG triplet in the short arm of chromoso -
me 4, manifested by motor symptoms, cognitive dysfunction
progressing to dementia, and various types of neuropsychiat -
ric disorders. The diagnosis of HD is confirmed by a gene tic
test, which may also be carried out presymptomatically.
Material and methods: We studied differences in psychiatric
examination and psychometric measures among the 52 peo-
ple at risk of HD, who were recommended to postpone or to
continue in the predictive protocol. In addition to the psy-
chiatric examination, we administered the Eysenck Person-
ality Questionnaire (EPQ-A), the Symptom Checklist 90
(SCL-90), and quality of life questionnaire (MANSA).
Results: People at risk of HD with the recommended test
postponement showed lower rate of neuroticism and EPQ-A
lie score, higher values on the phobia and the so-called ‘pos-
itive symptom distress index’ in SCL-90 and lower quality of
life than people at risk of HD with the recommendation to
continue.
Conclusions: Our results indicate that the formalized testing
does not bring significant information whereas the clinical
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St reszc zen ie
Wstêp i cel pracy: Choroba Huntingtona (ChH) jest dzie-
dziczon¹ autosomalnie dominuj¹co chorob¹ zwyrodnieniow¹
uk³adu nerwowego ze zwiêkszon¹ liczb¹ powtórzeñ trypletów
CAG na krótkim ramieniu chromosomu 4. Manifestuje siê
zaburzeniami ruchowymi, zaburzeniami poznawczymi po -
stêpuj¹cymi do otêpienia oraz rozmaitymi zaburzeniami neu-
ropsychiatrycznymi. Rozpoznanie ChH jest potwierdzane
badaniem genetycznym, które mo¿e byæ wykonywane równie¿
u osób przed wyst¹pieniem objawów klinicznych.
Materia³ i metody: Autorzy oceniali ró¿nice w zakresie wyni-
ków badania psychiatrycznego i miar psychometrycz nych wœród
52 osób zagro¿onych rozwojem ChH, u których za lecano kon-
tynuowanie lub odroczenie postêpowania zmierzaj¹cego do
wykonania badania genetycznego. Oprócz badania stanu 
psychicznego stosowano Eysenck Personality Questionnaire
(EPQ-A), Symptom Checklist 90 (SCL-90) oraz kwestionariusz
oceniaj¹cy jakoœæ ¿ycia (MANSA).
Wyniki: Osoby zagro¿one wyst¹pieniem ChH, u których
zalecano odroczenie badania genetycznego, uzyskiwa³y mniej -
sz¹ punktacjê w skali Neurotyzmu i K³amstw EPQ-A,
wiêksz¹ punktacjê w skali oceny fobii i tzw. dodatniego wskaŸ -
nika obci¹¿enia objawami w SCL-90, a tak¿e mia³y gorsz¹
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Introduction
Huntington disease (HD) is an autosomal dominant
hereditary neurodegenerative disease with multiplica-
tion of CAG triplet in the short arm of chromosome 4
[1], manifested by motor symptoms (chorea, dystonia,
postural instability and voluntary movements impair-
ment are typical in particular), cognitive dysfunction
progressing to dementia, and various types of neuro -
psychiatric disorders (behavioral, affective, etc.). Since
1993, this mutation can be determined in both patients
and ‘people at risk’ of HD (PAR). People at risk are
immediate offsprings or siblings of patients or persons
tested positive for HD.
The information on carrier status is burdened with
a high stress level and serious consequences for further
quality of life: the disease is incurable and causes pro-
gressing devastation of the motor and mental status,
entails 50% hereditary risk for the next generation, and
last but not least, it also has multiple negative impacts
on ‘healthy’ family members. Presymptomatic testing
related to this fatal diagnosis is thus associated with many
ethical problems [2,3].
An international protocol-based presymptomatic
testing procedure has been designed with the aim to
minimise the disastrous consequences [4], which in -
cludes several genetic consultations and neurological,
psychological and psychiatric examinations. Individual
sessions are aimed at providing a detailed introduction
of the disease and the testing procedure to the appli-
cant, and subsequently at verifying his/her insight in
the issue, clarifying his/her motivation and benefit of
the test, and last but not least, at determining the appli-
cant’s adaptation mechanisms to burdensome situations.
The entire process of the predictive protocol reduces
the risk of suicidality considerably [5]; however, with-
out eliminating it. Short-term and long-term conse-
quences of predictive testing have been dealt with in
many studies [5-14].
Physicians may not forbid the applicant to do the pre-
dictive test as per the protocol; however, they may rec-
ommend its postponement. Besides clear contraindica-
tions such as suicidality and depression, a whole number
of other situations may arise whose importance is deter-
mined on quite a subjective basis though, depending on
the personality of the given psychiatrist (for example,
willingness to accept risk versus preference of a totally
formal attitude with no personal engagement of the exam-
ining person). As a rule, the psychiatrist recommenda-
tion to continue or postpone the test stems only from clin-
ical experience. The most important role in this respect
is probably played by the motivation of the PAR or its
absence or vagueness, respectively; furthermore by their
personality structure, maturity, adaptation mechanisms,
duration of HD awareness and knowledge of the issue,
quality of their background and other factors.
Many years of experience with the predictive protocol
at many centres worldwide show that the implementation
rate of the genetic test in PAR is relatively low, ranging
between 5% and 25% in various countries [15-21].
The aim of our work is to characterize the differ-
ences in psychiatric examination and psychometric 
measures between PAR who were recommended to
postpone the test, and persons at risk who were recom-
mended to continue the predictive protocol. Our results
could have an additional value for those psychiatrists
who are less experienced or educated in complex assess-
ment of PAR in the process in predictive protocol.
Material and methods
In total, 162 persons at risk of HD asked for the pre-
dictive test between 2003 and 2009. The persons were
jakoœæ ¿ycia ni¿ osoby zagro¿one ChH, u których zalecano
kontynuowanie procedury zmierzaj¹cej do wykonania bada-
nia genetycznego.
Wnioski: Uzyskane wyniki wskazuj¹, ¿e sformalizowana oce-
na nie dostarcza istotnych informacji, podczas gdy kliniczne
badanie psychiatryczne pozostaje g³ównym czynnikiem decy-
duj¹cym o zalecaniu wykonania badania genetycznego. Naj-
wa¿niejszym czynnikiem w podejmowaniu decyzji jest moty-
wacja osób zg³aszaj¹cych siê na badanie.
S³owa kluczowe: choroba Huntingtona, predykcyjne bada-
nia genetyczne, osoby obci¹¿one ryzykiem.
psychiatric examination remains the main decisive factor in
the recommendation to perform a predictive genetic test. 
The motivation of applicants is considered as the most impor-
tant factor in the decision-making proces.
Key words: Huntington disease, predictive genetic test, people
at risk.
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acquainted with the protocol procedure based on the
international recommendation [4] and started under-
going individual examinations performed by our mul-
tidisciplinary team.
Out of this number, 52 persons (32 women, 20 men,
mean age 33 years, standard deviation [SD] 8.8 years,
range: 20-57 years) followed the protocol as far as to
undergo the psychiatric examination, which is its final part.
The fundamental psychiatric examination includes
a structured questionnaire defined by the international 
protocol and related particularly to the HD knowledge,
motivational questions and adaptation mechanisms, as 
well as common clinical exploration of medical history
and psychopathology with subsequent elaboration of an
objective finding. In our study, the applicants were more-
over examined also using Eysenck Personality Question -
nai re (EPQ-A) [22] in order to capture basic personal-
ity characteristics, and the self-assessment The Symptom
Checklist 90 (SCL-90) [23]. Finally, the applicants com-
pleted the Quality of Life Questionnaire (MANSA)
[24]. Further testing was not bearable due to the overall
duration of the examination (duration of approx. 3-4
hours). Recommendations concerning further procedure
in the preparatory protocol were provided based on the
clinical examination; the tests were analysed ex post.
Out of 52 PAR who asked for the presymptomatic
test, postponement was recommended to 11 applicants
(5 men and 6 women) (group C); out of the remaining
41 individuals, 19 were tested subsequently with posi-
tive results (group A), i.e. the mutation was confirmed,
and the gene carrier status was excluded in 22 persons
(group B). Essential characteristics of individual groups
are shown in Table 1. Twenty-five from 41 (61%) test-
ed PAR, and 4 from 11 (36.4%) PAR with recom-
mended postponement had children.
The results were statistically processed using the
non-parametric Mann-Whitney test or the Kolmogorov-
Smirnov test.
Results
Persons at risk with recommended postponement of
the test showed statistically significantly higher neuroti-
cism level; however, also a significantly lower EPQ-A
lie score than persons who were recommended to con-
tinue the test – see Table 2.
As for the General Psychopathology Scale (SCL-90),
PAR with recommended postponement of the test
showed significantly higher values only for the phobia
scale and for the so called ‘positive symptom distress
PAR tested positive later PAR tested negative later PAR with recommended 
postponement
Number 19 22 11
Sex (women/men) 11/8 15/7 6/5
Age [years]; mean ± SD 32.9 ± 7.6 34.6 ± 9.3 30 ± 9.9
Age [years]; range 21-57 22-57 20-49
Education [years]; > 12/ < 12 15/4 19/3 10/1
Partnership [yes/no] 15/4 20/2 9/2
Children [yes/no] 12/7 13/9 4/7
Table 1. Demographic data of studied patients at risk (PAR)
PAR – ‘people at risk’ of HD, SD – standard deviation
Mean of tested patients at risk Mean of patients at risk p value
(group A + B) with postponement (group C)
EPQ-N 7.53 11.09 0.019
EPQ-E 10.70 11.36 0.34
EPQ-L 5.19 3.81 0.014
Table 2. Results of Eysenck Personality Questionnaire (EPQ) in patients at risk group with recommended continuation of the test compared to the group with recom-
mended postponement
EPQ-N – neuroticism subscore, EPQ-E – extraversion subscore, EPQ-L – lie score
Group A – individuals tested positive later, group B – individuals tested negative later
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index’ that characterizes mean seriousness of a symptom
– see Table 3. Persons with recommended postpone-
ment of the test showed statistically significantly lower
quality of life based on MANSA scale than PAR who
continued the test.
The listing of specific reasons that led to the recom-
mendation of postponing the genetic test in 11 PAR is
shown in Table 4.
Discussion
The predictive protocol represents not only stress
and difficult decisions for PAR; it is also a heavy bur-
den of responsibility and making decisions for the med-
ical team found in a dilemma of respecting the autono-
my and preferring the benefit for PAR [8,25]. A lot of
studies have been done dealing with the issue of pre-
dictive testing and PAR problems. However, most of
them take into account particularly incipient subclinical
prediagnostic markers of the disease and their progres-
sion [26,27]. Another large group of studies focuses on
the PAR dilemma in its entire complexity [2,8,25,28-
32]. However, according to our knowledge, no studies
have been elaborated, which would discuss the dilem-
mas of professionals and offer possibilities of an optimal
procedure in non-standard or atypical PAR.
The psychiatrist decision of recommending the
genetic test or its postponement is often very difficult,
burdened with a certain level of doubts inside of the
physician whether he/she has made the right decision.
Formalized procedures and scopes of examination show
significant differences at individual centres. Some facts
that provide evidence of the need to postpone the gene t-
ic test are apparent – depression, suicidal ideation, par-
alyzing anxiety, or asking for the test due to external
pressure without feeling any need inside [4]. Some cen-
tres where the predictive protocol has been implement-
ed stem only from these few minimal non-surpassable
criteria and all the other parameters are omitted. Low-
er risks and consequences fall entirely in the PAR com-
petences and making an intervention in them is viewed
as an intervention in the PAR’s autonomy.
On the contrary, other centres including ours under-
take a much more global evaluation of the PAR’s status
in the deciding process, while an assessment and feed-
back for the PAR are deemed to be a mandatory part of
the whole protocol, which obviously includes an overall
evaluation of the psychopathological and further clini-
cal finding, of the social context, adaptation mechanisms
and in particular, motivation for undergoing the test.
However, even an experienced psychiatrist may doubt
his/her own decision. The psychiatrist’s surety could be
Mean ± SD (A + B) Median ± IQR (A + B) Mean ± SD (C) Median ± IQR (C) p value
GSI 37.21 ± 23.83 34.00 ± 25.25 59.82 ± 47.33 49.00 ± 37.75 0.114
PST 27.68 ± 14.28 28.00 ± 17.50 37.54 ± 22.15 38.00 ± 29.75 0.197
PSDI 1.32 ± 0.27 1.22 ± 0.29 1.47 ± 0.30 1.36 ± 0.28 0.028
SCL-90 subscores
Somatisation 4.66 ± 3.88 5.00 ± 6.00 6.82 ± 7.05 4.00 ± 8.50 0.620
Obsession-compulsion 8.05 ± 4.42 7.00 ± 5.25 10.18 ± 6.00 10.00 ± 9.50 0.305
Interpersonal sensitivity 4.93 ± 4.08 4.00 ± 6.00 7.73 ± 6.74 5.00 ± 6.75 0.219
Depression 5.68 ± 5.06 4.00 ± 6.00 9.73 ± 8.40 8.00 ± 8.75 0.112
Anxiety 4.07 ± 3.33 3.00 ± 3.25 6.18 ± 6.66 3.00 ± 2.00 0.504
Anger-hostility 1.76 ± 1.97 1.00 ± 1.25 3.82 ± 4.85 2.00 ± 2.75 0.149
Phobia 1.20 ± 1.33 1.00 ± 2.00 3.18 ± 3.03 2.00 ± 3.75 0.013
Paranoidity 2.54 ± 2.42 2.00 ± 2.00 4.18 ± 4.51 2.00 ± 6.00 0.499
Psychoticism 1.68 ± 2.35 1.00 ± 2.00 3.36 ± 4.25 1.00 ± 5.75 0.465
Table 3. Results of General Psychopathology Scale (SCL-90) in patients at risk with recommended continuation of the test compared to the group with recommended
postponement
GSI – overall score of SCL-90 scale, PST – number of items with non-zero scores, PSDI – total score/PST, A – individuals tested positive later, B – individuals tested negative later, 
SD – standard deviation, median A + B – median value in the group recommended to continue the test, IQR – interquartile range, C – individuals with recommended postponement
Neurologia i Neurochirurgia Polska 2013; 47, 6538
Tereza Uhrová, Jana Didovská, Jana Koblihová, Jirˇí Klempírˇ , Veronika Majerová, Jan Roth
Sex, age Reasons for recommending postponement
♀33 Has an identical twin who does not want to know the result
Protracted partnership problems with high probability of separation if the result is positive
Insufficient further background (cold relationships with the parents)
Reduced adaptation mechanisms; repeated need of psychological care in burdensome situations in the medical history
Expectation of a ‘favourable’ test result that will solve all other problems
Tenacious effort to avoid standard psychological examination in the protocol (attempt at its replacement with a vague 
report of a psychologist of the applicant’s workplace)
♂31 Obtaining a clearly favourable result is the main motivation; ‘certainty of being healthy’
Considers a possibility of not testing himself but the foetus – ‘if the foetus tests negative, a hope would remain’
The test and considerations in respect of a future descendant have not been consulted with the partner
Nonverbal manifestations indicate that he actually does not want any test
♀38 Insufficient background: Anomalous personality of the husband incapable of being confronted with HD, 
unable to provide support
♂49 An effort to meet the son’s wish is the only motivation
Massive pressure on part of the family
Insufficient knowledge of HD
Presence of psychopathology requiring medication (dysthymia)
♀22 ‘Unconvincing’ motivation
Elevated risk level that the initial stage may be present – benefit of the result for the future should be clarified
♂29 Current diagnosis of generalized anxiety disorder in a predisposed personality – priority need of treatment
The utterance indicates that the applicant actually is not interested in the test; his major need consists in clarifying 
his current problems
♂21 Insufficient information about HD; non-clarified motivation
HD tabuised by the mother (burden on part of the father) causing that the mother is not informed about the son’s test either
The mother would most likely not be able to deal with a positive result and would not be able to provide support; 
on the contrary, she would increase the stress level unbearably
♂22 Non-clarified motivation
Clear expectation of a favourable result combined with immature and neurotic personality disposition
Reduced adaptation mechanisms
Absolute absence of any benefit of information on positivity
Plans for the future quite independent of the result
Questionable background
♀43 Debatable adaptation mechanisms
Controversial ability of support on part of the husband
Side diagnosis of premenstrual syndrome
Recommendation of postponement was suggested only as one of the possibilities – and was welcome by the applicant herself
Table 4. Specific reasons for recommending presymptomatic test postponement in 11 applicants
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enhanced by obtaining additional arguments having 
the role of warning or positive signals that the conse-
quences of the genetic test are managed, and which in
our opinion could reduce the subjective nature of his/her
decision. This is why we tried to seek such indicators
using our preset battery of scales and tests mapping psy-
chopathological symptoms of the whole spectrum and
the personality.
The aim of the psychiatric examination in the pre-
dictive protocol is to assess the HD knowledge, pre-
paredness for an adverse outcome, adaptative mecha-
nisms, as well as present and potentially high-risk
psychopathology. The tests we selected were targeted at
related characteristics, i.e. personality (EPQ-A), gen-
eral psychopathology (SCL-90) and the quality of life
(MANSA).
Our results indicate that the PAR group with post-
ponement differs from the group undergoing the test
only in a higher level of neuroticism and on the contrary,
in a lower lie score, higher distress and higher score of
the phobia scale.
Specific reasons were highly diverse and individual in
our 11 PAR with recommended postponement, and thus
cannot be capture using a unified scale battery. No one of
them strictly fulfilled the given contraindications autho-
rizing to refuse the test; only postponement was recom-
mended in all of them, while its reasons were discussed
in detail with the PAR. In a certain way, it was surprising
that all 11 PAR accepted the recommendation and no one
of them insisted on performing the test. For our part, it
was not a strict recommendation or order to postpone the
test; it was only a warning concerning risk factors found
that were discussed in detail in the final interview with
PAR. The decision was always up to PAR.
Problematic motivation was the most significant rea-
son (7 cases) for postponing the test; furthermore, insuf-
ficient background and absence of support occurred in
5 cases, and impaired adaptation mechanisms in 4 cas-
es. Assessing the motivation is very difficult: Quite an
identical answer (usually ‘I just want to know in order
to plan my things accordingly’) has quite a different
meaning in various PAR based on their personality
structures and the overall context of the life situations.
These reasons were captured by the psychiatric
examination and showed no convincing correlate in the
tests performed. Higher neuroticism found in EPQ-N,
higher overall distress and higher phobia score in SCL
are considered as secondary consequences of the indi-
vidual reasons for postponement detected by us. How-
ever, these pathological scores cannot be used to make
opposite deductions, i.e. the finding itself of increased
neuroticism or distress need not indicate presence of
a serious reason to postpone the test.
The reasons explaining superiority of the psychiatric
examination conclusions over the data obtained using
the scale battery may be as follows: (1) the test battery
chosen by us is not sufficiently sensitive or is not capa-
ble of encompassing the decisive factors; (2) factors
important in the deciding process regarding the test are
not scalable – and neither our chosen ones nor other
Sex, age Reasons for recommending postponement
♀20 Absence of personal experience with HD and at the same time, vehement refusal of personal confrontation with HD 
and of obtaining information
Short time of awareness of HD existence in the family
Progressing psychosomatic problems with impaired social functioning, together with puzzling minimal effort to solve 
the problems
Need of proper diagnostics of psychosomatic problems and subsequent therapy
Very vague motivation to undergo the test
Markedly immature personality with impaired adaptation mechanisms
Problematic relationship with the partner
♀22 Suspected initial stage of the disease – the test is motivated by an effort to determine the cause of the current problems
At the same time, fear of the results, would like to keep some hope – asking for the test due to the pressure of external 
circumstances (problems at work due to initial symptoms)
Visible relief when a possibility to solve the situation is proposed which does not necessitate the test
Table 4. Cont.
♀ female; ♂ male; HD – Huntington disease
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scaling and testing methods capture the complexity of
life, inner motives and their connectedness with the
social context and possibly psychopathology; this broad
context can be understood only by clinical examination
and cannot be replaced with scaling even if extensive;
(3) highly speculative alternative explanation might stem
from the determination of a lower lie score in PAR with
recommended postponement (persons with a higher lie
score, i.e. with better self-presentation and higher cen-
sorship of psychological difficulties would ‘pass’ through
the preparation); (4) if the testing fails to provide objec-
tive warning signs and the psychiatrist evaluation is bur-
dened with a significant subjectivity level, it is possible
that the psychiatrist recommendation to postpone or con-
tinue the protocol has no significant value and the post-
ponement may be indicated needlessly; this explanation
was contradicted by 100% acceptance of the recom-
mendation in our set – none of the probands was ‘for-
bidden’ to pass the test, and all of them were only in -
formed of the reasons why we deemed the postponement
to be a more advantageous choice.
It was a shortcoming of our study that we also had
not obtained data in the post-test period. This was due
to low PAR compliance, their unwillingness to take part
in examinations during this period, as well as the need to
travel long distances (during the study, predictive test-
ing was only conducted in one centre in the Czech
Republic). Another shortcoming of the study was the
selection of psychometric tests in 2002, which would now
be constructed differently, based on new knowledge.
Regarding the quality of life measured using
MANSA scale, we found that PAR with recommend-
ed test postponement showed a significantly worse qual-
ity of life than PAR who continued the test. In our opin-
ion, this finding is in accordance with some specific
reasons for recommending postponement (insufficient
social background, partnership issues, etc.). The Qual-
ity of Life Questionnaire is the only one of all the scales
applied that is related to multiple areas forming the
applicant’s life, and thus it is the only scale used in our
research that may grasp in a certain extent the complexity
of evaluation within the framework of the psychiatric
examination.
In our opinion, the quality of life accurately reflects
the degree of distress during decision making. It is an
important supporting argument for appropriate timing
of the test. Within the subsequent communication of an
adverse test result, the accumulation of more life stres-
sors represents higher risks for a breakdown in the adap-
tative mechanisms.
Conclusions
1. The results of our study indicate that formalized psy-
chological testing (taking the form of our battery at
the minimum) in prediction of the recommendation
to perform the genetic test or to postpone the test pro-
vides no significant information.
2. Clinical psychiatrist examination remains the decisive
factor in the process of indicating or postponing the
predictive genetic HD test.
3. Motivation of the applicant is considered by us to be
one of the most important factors in the deciding
process, which cannot be assessed by a scaling’ pro-
cedure.
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